GMC's guidance may inhibit researchBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7302.1601 (Published 30 June 2001) Cite this as: BMJ 2001;322:1601
- Stephen J Leslie, British Heart Foundation research fellow,
- David J Webb, professor of clinical pharmacology (firstname.lastname@example.org)
- Clinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU
EDITOR—Academic clinical research, including the evaluation of new treatments, is central to providing high quality, cost effective care to patients, and it requires the cooperation and goodwill of the patients who volunteer to participate. The research process is externally regulated and monitored by ethics committees to ensure that patients are protected.
We welcome the debate on the Data Protection Act and access to patients' records,1–3 and wish to raise a related concern about the General Medical Council's recent guidelines on …